IsoRay (ISR) Preliminary Q3 Revenue of $1.57 Million

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to IsoRay (ISR) Preliminary Q3 Revenue of $1.57 Million

IsoRay Announces Preliminary Third Quarter Fiscal 2018 Revenue of $1.57 Million, 23% Year-over-Year Increase

April 18, 2018 8:30 AM EDT

RICHLAND, Wash, April 18, 2018 (GLOBE NEWSWIRE) -- IsoRay, Inc. (NYSE American: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and gynecological cancers, today announced preliminary unaudited revenue and gross profit results for the third quarter of fiscal 2018 ended March 31, 2018.

Preliminary revenue and gross profit for the third quarter of fiscal 2018 was as follows:

Preliminary revenue for the three months ended March 31, 2018, was $1.57 million compared to $1.28 million... More